drugset / Trial / NCT01514487
Comparison of Three Liraglutide Formulations in Healthy Volunteers
RandomizedCrossoverDouble-blindTreatment
Summary
This trial is conducted in Oceania. The aim of this trial is to test for bioequivalence between each of the two new liraglutide formulations at pH 7.9 and 8.15 and the planned Phase 3 formulation at pH 7.7.
Timeline
- Start
- 2005-01-13
- Primary completion
- 2005-03-30
- Completion
- 2005-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Liraglutide | Peptide | 0.75 mg | Other |